Dr. Lee Schwamm, vice president of virtual care/digital health at Mass General Brigham said this at the virtual event World Medical Innovation Forum hosted by Partners HealthCare on Monday.
Despite continued economic impacts from the Covid-19 pandemic, biotechnology companies and VC firms raised significant amounts of funding this week. For example, Massachusetts-based Pandion Therapeutics closed $80 million in funding to develop a therapeutic designed to treat autoimmune diseases.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
AristaMD, a San Diego-based startup facilitating eConsults, raised $18 million in a series B round led by Cigna Ventures and MemorialCare Innovation Fund. The company plans to use the additional funds to expand its footprint across the U.S.
Rebecca Cofinas, AristaMD CEO, said in response to emailed questions: "We see ourselves as experts focused on a single but critical issue. We dramatically improve the specialist referral process and allow physicians to collaborate in real-time."